Medtronic is sponsoring and hosting several events during this year's STS meeting.
See the lineup below!
Innovation Center at STS
Booth #1331
Join Medtronic and faculty for in-booth presentations and hands-on experience with our suite of Cardiac Surgery products including the NEW Penditure LAA Exclusion System, Avalus Bioprosthesis, the Crescent™* catheter and more! Schedule subject to change.
| Date / Time | Topic | Faculty |
|---|---|---|
| Saturday, Jan. 27th | ||
| 9:00 - 9:45 am | In-booth presentation: Aortic root enlargement with Avalus valve | Bo Yang, M.D. |
| 10:00 - 11:00 am | Hands-on experience: LAA Exclusion with the Penditure device | Gregory Rushing, M.D. |
| 1:00 - 1:30 pm | Hands-on experience: LAA Exclusion with the Penditure device | Gianluca Torregrossa, M.D. |
| 2:45 - 3:45 pm | Hands-on experience: Aortic root enlargement with Avalus valve | Bo Yang, M.D. |
| 4:00 - 4:15 pm | Hands-on experience: LAA Exclusion with the Penditure device | Gregory Rushing, M.D. |
| 5:00 - 5:30 pm | In-booth presentation: OPCAB procedure with LAA Exclusion using Penditure device | Gianluca Torregrossa, M.D. |
| 5:30 - 6:15 pm | Hands-on experience: LAA Exclusion with the Penditure device | Gianluca Torregrossa, M.D. |
| Sunday, Jan. 28th | ||
| 9:45 - 10:15 am | In-booth presentation: Aortic root enlargement with Avalus valve | Marc Pelletier, M.D. |
| 10:15 - 10:45 am | Hands-on experience: Aortic root enlargement with Avalus valve | Marc Pelletier, M.D. |
| 11:40 - 11:50 am | In-booth presentation: Cannulation Strategies for Success | Prof. Roberto Lorusso, M.D. |
| 11:50 am - 12:45 pm | Hands-on experience: Complications in Cannulation: Strategies for Success | Prof. Roberto Lorusso, M.D., Bryan Whitson, M.D. and Mark Mazziotti, M.D. |
| 2:15 - 3:15 pm | Hands-on experience: LAA Exclusion with the Penditure device | Eric Lehr, M.D. |
| 4:00 - 4:30 pm | In-booth presentation: LAA Exclusion with the Penditure device | Basal Ramlawi, M.D. |
| Monday, Jan. 29th | ||
| 8:30 - 9:15 am |
Hands-on experience: LAA Exclusion with the Penditure device | Hal Roberts M.D. |
| 10:30 - 11:15 am |
In-booth presentation: Technical considerations for mitral & tricuspid valve repair | Arnar Geirsson, M.D. |
Extraordinary Women in Cardiothoracic Surgery Awards Breakfast
Medtronic is sponsoring The Extraordinary Women in Cardiothoracic Surgery Awards Breakfast. Kick off STS by honoring several outstanding women in cardiothoracic surgery who have achieved excellence in clinical practice as well as demonstrate leadership, mentorship, integrity, creativity, and expertise in carrying out day-to-day professional responsibilities.
Date: Saturday, January 27th
Time: 6:30 – 7:30 a.m. CST
Location: Grand Hyatt San Antonio River Walk
Lunch Symposium
Innovation, Evidence & Outcomes:
Penditure™ LAA Exclusion System and Avalus™ Bioprosthesis
Date: Saturday, January 27th
Time: 11:25 a.m. – 12:25 p.m. CST
Location: Room 217D,
Henry B. González Convention Center
Topics include:
- LAA management with the new innovative Penditure device during concomitant procedures
- Aortic Root Enlargement with the Avalus valve
- Hemodynamic Function of Contemporary Surgical Aortic Valves 1 Year Postimplant
- Real-World Evidence of SAVR in Complex Patients – ACE Registry Results
Gorav Ailawadi, M.D.
University of Michigan
Ann Arbor, Michigan
Basel Ramlawi, M.D.
Lankenau Heart Institute
Philadelphia, Pennsylvania
Bill Brinkman, M.D.
Baylor Scott & White
The Heart Hospital
Plano, Texas
Joseph Sabik, M.D.
University Hospitals Cleveland
Cleveland, Ohio
Prof. Bart Meuris, M.D., Ph.D.
K.U. Leuven
Leuven, Belgium
This session is an industry-supported satellite symposium and is not part of the STS Annual Meeting accredited program.
©2024 Medtronic. Medtronic, Medtronic logo, and Engineering the extraordinary are trademarks of Medtronic. All other brands are trademarks of a Medtronic company.
UC202408098a EN
Crescent™* jugular dual lumen catheter is manufactured by MC3, Inc. and exclusively distributed by Medtronic.
Penditure™ LAA Exclusion System
Indications:
The Penditure LAA Exclusion System is indicated for the exclusion of the left atrial appendage of the heart, performed under direct visualization and in conjunction with other cardiac surgical procedures. Direct visualization, in this context, requires that the physician can see the heart directly, with or without assistance from a camera, endoscope, and so forth, or any other appropriate viewing technologies.
Contraindications:
• Do not use this device if the patient has a known allergy to nitinol (nickel titanium alloy).
• Do not use this device as a contraceptive tubal occlusion device.
Potential Adverse Effects:
Possible complications related to the use of Penditure™ LAA exclusion system in combination with open heart surgery are: bleeding, tissue damage, thromboembolism, and pericardial effusion. For a complete listing of all indications, contraindications, precautions, and warnings, please refer to the Instructions for Use, which accompany each product.
Only physicians who are trained in standard cardiac surgical procedures can use this device.
For more information, contact your local Medtronic cardiac surgery representative. U.S. Customer Service: 1-800-328-1357
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For a listing of indications, contraindications, precautions, and warnings, please refer to the Instructions for Use.
Avalus™ Bioprosthesis
Indications: The Avalus bioprosthesis is indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic aortic valves.
Contraindications: None known.
Warnings/Precautions/Adverse Events: Only physicians who have received proper training in valve replacement should use this device. Accelerated structural deterioration due to calcific degeneration of bioprosthesis may occur in: children, adolescents, young adults, and patients with altered calcium metabolism (e.g., chronic renal failure, or hyperparathyroidism). Adverse events can include: angina, cardiac dysrhythmias, endocarditis, heart failure, hemolysis, hemolytic anemia, hemorrhage, infection other than endocarditis, transvalvular or paravalvular leak, myocardial infarction, nonstructural valve dysfunction (leaflet entrapment/impingement, obstructive pannus ingrowth, suture dehiscence, inappropriate sizing or positioning, or other), pericardial effusion or tamponade, prosthesis regurgitation, prosthesis stenosis, prosthesis thrombosis, stroke, structural valve deterioration (calcification, leaflet tear or perforation, or other), thromboembolism, tissue dehiscence, and transient ischemic attack. These complications could lead to reoperation, explant of the bioprosthesis, permanent disability, or death.
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.
For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use. For countries that use eIFUs, consult instructions for use at medtronic.com/manuals.